| The political origins of health inequity: prospects for change OP Ottersen, J Dasgupta, C Blouin, P Buss, V Chongsuvivatwong, J Frenk, ... The Lancet 383 (9917), 630-667, 2014 | 631 | 2014 |
| Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola S Moon, D Sridhar, MA Pate, AK Jha, C Clinton, S Delaunay, V Edwin, ... The Lancet 386 (10009), 2204-2221, 2015 | 563 | 2015 |
| Governance challenges in global health J Frenk, S Moon New England Journal of Medicine 368 (10), 936-942, 2013 | 461 | 2013 |
| Building a tuberculosis-free world: The Lancet Commission on tuberculosis MJA Reid, N Arinaminpathy, A Bloom, BR Bloom, C Boehme, R Chaisson, ... The Lancet 393 (10178), 1331-1384, 2019 | 282 | 2019 |
| Driving a decade of change: HIV/AIDS, patents and access to medicines for all E Hoen, J Berger, A Calmy, S Moon Journal of the International AIDS Society 14 (1), 15-15, 2011 | 262 | 2011 |
| Making technological innovation work for sustainable development LD Anadon, G Chan, AG Harley, K Matus, S Moon, SL Murthy, WC Clark Proceedings of the National Academy of Sciences 113 (35), 9682-9690, 2016 | 219 | 2016 |
| Making technological innovation work for sustainable development LD Anadon, G Chan, AG Harley, K Matus, S Moon, SL Murthy, WC Clark Proceedings of the National Academy of Sciences 113 (35), 9682-9690, 2016 | 219 | 2016 |
| Making Technological Innovation Work for Sustainable Development L Diaz Anadon, G Chan, AG Harley, K Matus, S Moon, SL Murthy, ... | 219* | 2015 |
| A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries B Waning, E Diedrichsen, S Moon Journal of the International AIDS Society 13 (1), 1-9, 2010 | 213 | 2010 |
| From sovereignty to solidarity: a renewed concept of global health for an era of complex interdependence J Frenk, O Gómez-Dantés, S Moon The Lancet 383 (9911), 94-97, 2014 | 191 | 2014 |
| Fatal Imbalance: the crisis in research and development for drugs for neglected diseases D Berman, D Smith, A Warpinski, S Moon, ... Médecins Sans Frontičres Access to Essential Medicines Campaign and the …, 2001 | 165* | 2001 |
| A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries S Moon, E Jambert, M Childs, T von Schoen-Angerer Globalization and Health 7 (1), 1-11, 2011 | 162 | 2011 |
| The global health system: actors, norms, and expectations in transition NA Szlezák, BR Bloom, DT Jamison, GT Keusch, CM Michaud, S Moon, ... PLoS Medicine 7 (1), e1000183, 2010 | 155 | 2010 |
| Innovation and access to medicines for neglected populations: could a treaty address a broken pharmaceutical R&D system? S Moon, J Bermudez, E 't Hoen PLoS medicine 9 (5), e1001218, 2012 | 120 | 2012 |
| Toward a common secure future: four global commissions in the wake of Ebola LO Gostin, O Tomori, S Wibulpolprasert, AK Jha, J Frenk, S Moon, ... PLoS medicine 13 (5), e1002042, 2016 | 117 | 2016 |
| Reimagining global health governance in the age of COVID-19 LO Gostin, S Moon, BM Meier American Journal of Public Health 110 (11), 1615-1619, 2020 | 106 | 2020 |
| Pricing of pharmaceuticals is becoming a major challenge for health systems SG Morgan, HS Bathula, S Moon bmj 368, 2020 | 94 | 2020 |
| Post-Ebola reforms: ample analysis, inadequate action S Moon, J Leigh, L Woskie, F Checchi, V Dzau, M Fallah, G Fitzgerald, ... Bmj 356, 2017 | 91 | 2017 |
| Global public goods for health: weaknesses and opportunities in the global health system S Moon, JA Rřttingen, J Frenk Health Economics, Policy and Law 12 (2), 195-205, 2017 | 76 | 2017 |
| Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets B Waning, M Kyle, E Diedrichsen, L Soucy, J Hochstadt, T Bärnighausen, ... Globalization and Health 6 (1), 1-19, 2010 | 76 | 2010 |
